TuHURA BIOSCIENCES, INC./NV Investing Cash Flow
TuHURA BIOSCIENCES, INC./NV (HURA) reported Investing Cash Flow of -$185.82 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-14
- TuHURA BIOSCIENCES, INC./NV net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$136.98K.
- TuHURA BIOSCIENCES, INC./NV net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$48.85K.
- TuHURA BIOSCIENCES, INC./NV net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$27.85K.
- TuHURA BIOSCIENCES, INC./NV net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $0.00.
- TuHURA BIOSCIENCES, INC./NV net cash provided by (used in) investing activities for fiscal 2025 was -$1.34M.
- TuHURA BIOSCIENCES, INC./NV net cash provided by (used in) investing activities for fiscal 2024 was -$6.05M.
- TuHURA BIOSCIENCES, INC./NV net cash provided by (used in) investing activities for fiscal 2024 was -$20.00K.
- TuHURA BIOSCIENCES, INC./NV net cash provided by (used in) investing activities for fiscal 2023 was -$1.30M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 30 month | Net Cash Provided by (Used in) Investing Activities 33 month | Net Cash Provided by (Used in) Investing Activities 36 month | Net Cash Provided by (Used in) Investing Activities 39 month | Net Cash Provided by (Used in) Investing Activities 42 month |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$136.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$185.82K 10-Q · filed 2026-08-14 | -$213.67K derived: sum of 3 quarters · filed 2026-08-14 | -$213.67K derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2026-03-31 | -$48.85K 10-Q · filed 2026-05-15 | -$76.70K derived: sum of 2 quarters · filed 2026-05-15 | -$76.70K derived: sum of 3 quarters · filed 2026-05-15 | -$233.16K derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-12-31 | -$27.85K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$27.85K derived: sum of 2 quarters · filed 2026-03-31 | -$184.31K derived: sum of 3 quarters · filed 2026-08-14 | -$1.34M 10-K · filed 2026-03-31 | |||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$156.46K derived: sum of 2 quarters · filed 2026-08-14 | -$1.31M 10-Q · filed 2025-11-14 | -$2.13M derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-06-30 | -$156.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$1.31M 10-Q · filed 2026-08-14 | -$2.13M derived: sum of 3 quarters · filed 2026-08-14 | -$7.32M derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-03-31 | -$1.15M 10-Q · filed 2026-05-15 | -$1.97M derived: sum of 2 quarters · filed 2026-05-15 | -$7.17M derived: sum of 3 quarters · filed 2026-05-15 | -$7.17M derived: sum of 4 quarters · filed 2026-05-15 | |||||
| 2024-12-31 | -$823.54K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$6.02M derived: sum of 2 quarters · filed 2026-03-31 | -$6.02M derived: sum of 3 quarters · filed 2026-03-31 | -$6.05M 10-K · filed 2026-03-31 | |||||
| 2024-09-30 | -$5.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$5.19M derived: sum of 2 quarters · filed 2025-11-14 | -$5.23M 10-Q · filed 2025-11-14 | ||||||
| 2024-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-10-07 | -$36.50K 10-Q · filed 2025-08-14 | -$20.00K 10-K · filed 2024-10-07 | ||||||
| 2024-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-14 | -$20.00K 10-Q · filed 2024-05-14 | |||||||
| 2023-12-31 | -$20.00K 10-Q · filed 2024-02-14 | -$1.30M 10-K · filed 2025-03-31 | |||||||
| 2023-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-10-07 | $0.00 derived: sum of 2 quarters · filed 2024-10-07 | $0.00 derived: sum of 3 quarters · filed 2024-10-07 | -$232.00K 10-K · filed 2024-10-07 | |||||
| 2023-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-14 | $0.00 derived: sum of 2 quarters · filed 2024-05-14 | -$232.00K 10-Q · filed 2024-05-14 | ||||||
| 2022-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14 | -$232.00K 10-Q · filed 2024-02-14 | |||||||
| 2022-09-30 | -$232.00K 10-Q · filed 2023-11-13 | ||||||||
| 2021-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | -$8.00K derived: sum of 2 quarters · filed 2022-09-27 | -$5.00K derived: sum of 3 quarters · filed 2022-09-27 | $964.00K 10-K · filed 2022-09-27 | |||||
| 2021-03-31 | -$8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-13 | -$5.00K derived: sum of 2 quarters · filed 2022-05-13 | $964.00K 10-Q · filed 2022-05-13 | ||||||
| 2020-12-31 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-11 | $972.00K 10-Q · filed 2022-02-11 | |||||||
| 2020-09-30 | $969.00K 10-Q · filed 2021-11-15 | ||||||||
| 2018-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-09 | -$12.65K 10-K · filed 2019-09-09 | |||||||
| 2018-03-31 | -$12.65K 10-Q · filed 2019-05-14 | ||||||||
| 2017-06-30 | -$20.96K 8-K · filed 2019-06-03 | ||||||||
| 2016-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13 | $0.00 derived: sum of 2 quarters · filed 2017-05-12 | -$16.76K 10-K · filed 2016-09-13 | ||||||
| 2016-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-12 | -$16.76K 10-Q · filed 2017-05-12 | |||||||
| 2015-12-31 | -$16.76K 10-Q · filed 2017-02-10 | ||||||||
| 2012-12-31 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-01-18 | $0.00 10-Q · filed 2013-01-18 | $0.00 derived: sum of 3 quarters · filed 2013-01-18 | $0.00 derived: sum of 4 quarters · filed 2013-01-18 | $0.00 10-Q · filed 2013-01-18 | ||||
| 2012-09-30 | $0.00 10-Q/A · filed 2012-12-20 | $0.00 derived: sum of 2 quarters · filed 2012-12-20 | $0.00 derived: sum of 3 quarters · filed 2012-12-20 | $0.00 derived: sum of 4 quarters · filed 2013-01-18 | $0.00 10-Q/A · filed 2012-12-20 | ||||
| 2012-06-30 | $0.00 10-K/A · filed 2012-12-20 | $0.00 derived: sum of 2 quarters · filed 2012-12-20 | $0.00 derived: sum of 3 quarters · filed 2013-01-18 | $0.00 10-K/A · filed 2012-12-20 | $0.00 10-K/A · filed 2012-12-20 | ||||
| 2012-03-31 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2012-06-05 | $0.00 derived: sum of 2 quarters · filed 2013-01-18 | $0.00 10-Q/A · filed 2012-06-05 | $0.00 derived: sum of 4 quarters · filed 2013-01-18 | $0.00 10-Q/A · filed 2012-06-05 | ||||
| 2011-12-31 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-01-18 | $0.00 10-Q · filed 2013-01-18 | $0.00 derived: sum of 3 quarters · filed 2013-01-18 | $0.00 derived: sum of 4 quarters · filed 2013-01-18 | $0.00 10-Q · filed 2012-02-07 | ||||
| 2011-09-30 | $0.00 10-Q/A · filed 2012-12-20 | $0.00 derived: sum of 2 quarters · filed 2012-12-20 | $0.00 derived: sum of 3 quarters · filed 2012-12-20 | ||||||
| 2011-06-30 | $0.00 10-K/A · filed 2012-12-20 | $0.00 derived: sum of 2 quarters · filed 2012-12-20 | $0.00 10-K/A · filed 2012-12-20 | ||||||
| 2011-03-31 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2012-06-05 | $0.00 10-Q/A · filed 2012-06-05 | |||||||
| 2010-12-31 | $0.00 10-Q · filed 2012-02-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |